iiinova — where your digital self keeps evolving

Luke Davis, MD @ldavismd.bsky.social · 11/11/2025

Are you a US-based early- to mid-career researcher looking to help End the HIV Epidemic in the US through a new or existing community partnership? ISCI, with Yale R3EDI Hub & the CHESHIRE Network, are accepting applications the HIV IS Visiting Scholars program thru 1/4/26. 👉: tinyurl.com/3dyp67f6

010

Reposted by Luke Davis, MD

Yale School of Public Health @yalesph.bsky.social · 30/10/2025

Our Yale Center for Methods in Implementation and Prevention Science is a global leader in the rapidly expanding discipline of implementation science. We’re advancing public health by creating new methods to implement evidence-based interventions in clinical and community settings. 1/2

youtube.com

What Sets Yale School of Public Health's Implementation Science Program Apart?

YouTube video by Yale School of Public Health

261

Luke Davis, MD @ldavismd.bsky.social · 17/09/2025

Check out the closing sessions on the 24 Hours to Save AIDS Research website and catch all of the recordings on YouTube! 👉 saveaidsresearch.org 👉 www.youtube.com/live/C3wxhML... #EndHIV #EndTB #24HoursToSaveAIDSResearch @yalesph.bsky.social @yaleschoolofmed.bsky.social

saveaidsresearch.org

24 Hours to Save AIDS Research

010

Luke Davis, MD @ldavismd.bsky.social · 17/09/2025

Was pleased to kick off Hour 22 of the 24 Hours to Save AIDS Research this morning with host and my friend and Yale colleague Jeffrey Wickersham, talking about TB-HIV implementation science. Thanks to all the organizers for an amazing celebration of the transformative impact of HIV research

110

Reposted by Luke Davis, MD

@YaleEMD @yaleemd.bsky.social · 08/09/2025

🎉✨👏 Welcome to a new academic year in the Department of Epidemiology of Microbial Diseases at the Yale School of Public Health! We’re excited to continue learning, collaborating, and advancing public health together.

2116

Luke Davis, MD @ldavismd.bsky.social · 08/09/2025

That science will be on display during the 24 Hours to Save AIDS Research event, starting Sept 16 at 11a EDT. I'll be speaking about progress in HIV-TB research on Sept 17 at 8a 👉 Other speakers & highlights here: saveaidsresearch.org#schedule Spread the word! #HIV #PublicHealth #Research

saveaidsresearch.org

24 Hours to Save AIDS Research

000

Luke Davis, MD @ldavismd.bsky.social · 08/09/2025

The research driving those gains is now threatened, despite the fact that HIV research has had far ranging impacts on numerous fields byond HIV, from immunology and virology, to clinical medicine and public health, to regulatory policy and practice. 🦠 🔬 🏥

saveaidsresearch.org

24 Hours to Save AIDS Research

110

Luke Davis, MD @ldavismd.bsky.social · 08/09/2025

📣 Over the past 40+ years, the HIV/AIDS community - led by people living with HIV, their families, friends, and loved ones, and supported by clinicians, researchers, funders, and policymakers - has saved literally millions of lives, a modern miracle of medicine, public health, and advocacy.

saveaidsresearch.org

24 Hours to Save AIDS Research

120

Luke Davis, MD @ldavismd.bsky.social · 02/09/2025

👏 Proud of my Yale colleagues Gregg Gonsalves and Jeff Wickersham for helping organize this important event. Grateful for their strong and consistent leadership in advancing HIV/AIDS research and public health! #EndHIV #PublicHealth #Research @gregggonsalves.bsky.social

021

Reposted by Luke Davis, MD

@YaleEMD @yaleemd.bsky.social · 28/05/2025

Morgan completed her MD/PhD at UNC Chapel Hill and came to Yale through the Internal Medicine (IM) Physician Scientist Training Program. Now in the Infectious Diseases (ID) fellowship, she is mentored by EMD faculty Dr. Sunil Parikh and Dr. Amy Bei. 👉 Learn more here: lnkd.in/dgEvDxRT

lnkd.in

This link will take you to a page that’s not on LinkedIn

022

Reposted by Luke Davis, MD

@YaleEMD @yaleemd.bsky.social · 28/05/2025

🥳📢 Introducing the EMD Postdoc Spotlight series! Dr. Morgan Goheen is a postdoctoral fellow in the Parikh and Bei Labs, whose research investigates the impact of human antimalarials ingested by mosquitoes feeding on people taking these drugs, parasite development, and selection within the vector.

121

Reposted by Luke Davis, MD

@YaleEMD @yaleemd.bsky.social · 27/05/2025

In honor of Hepatitis Awareness Month and Hepatitis Testing Day on May 19, we’re proud to share an insightful article by Yiyun (Patricia) Pan, MPH/MBA, a recent graduate of the Yale School of Public Health and Yale School of Management. 🔗 Read her full article here: lnkd.in/ehxReXUu

111

Luke Davis, MD @ldavismd.bsky.social · 02/04/2025

The Yale Center for Methods in Implementation and Prevention Science (CMIPS) conducts cutting edge implementation research and offers advanced training at MPH, MS, PhD, and post-doctoral fellow level Learn more through the videos and web links below!

ysph.yale.edu

CMIPS Team

000

Luke Davis, MD @ldavismd.bsky.social · 24/03/2025

➡️ Supporting people with TB to adhere to medications and complete treatment ➡️ Encouraging screening and prevention among close ➡️ Fighting stigma against people with TB in all its forms #ENDTB #WorldTBDay

000

Luke Davis, MD @ldavismd.bsky.social · 24/03/2025

Therefore, together with communities around the world, clinicians, public health practitioners, and policymakers must do more, including ➡️ Educating people about TB symptoms & diagnosis ➡️ Raising awareness treatment is usually curative & free in most places once accessed

100

Luke Davis, MD @ldavismd.bsky.social · 24/03/2025

Yet with 1/4 of the world's rapidly growing population TB infected - over 2 billion people - the absolute number of people who will progress from infection to active TB disease every year is huge and continues to grow. On World TB Day 2025, that's an unhappy 😒 fact that we must also face.

100

Luke Davis, MD @ldavismd.bsky.social · 24/03/2025

📣 Against current uncertainties for TB control and elimination, the global community 🌍 can look back on 2 decades of remarkable progress in the fight against TB 🏥, as TB incidence rates have fallen by 25% and TB death rates by 50%. The millions of lives saved is truly something to be happy 😃 about!

100

Luke Davis, MD @ldavismd.bsky.social · 13/02/2025

My colleague Gregg Gonsalves tells of the enormous human cost when South African leaders denied the existence of HIV & how South Africans responded by taking back science for themselves. "Those who fail to learn the lessons of history are doomed to repeat it." www.nytimes.com/2025/02/13/o...

nytimes.com

Opinion | I Shudder to Imagine Kennedy Running Our Health Agencies.

We have to go toe-to-toe with this administration and resist its attacks on public health.

021

Luke Davis, MD @ldavismd.bsky.social · 13/12/2024

6/👉Contextual factors influencing bubble continuous positive airway pressure implementation for paediatric respiratory distress in low-income and middle-income countries: a realist review. The Lancet Global Health lnkd.in/dHpfA2Ey @nadir_ijaz #GlobalHealth #bCPAP #impsci

020

Luke Davis, MD @ldavismd.bsky.social · 13/12/2024

5/ These findings provide a roadmap for future research to adapt bCPAP interventions and design context-sensitive implementation strategies. Our goal? Ensure bCPAP is used safely and effectively to save lives, no matter the context.🌍

120

Luke Davis, MD @ldavismd.bsky.social · 13/12/2024

4/ Using a realist, theory-driven approach, we developed a program theory identifying 18 contextual factors and mechanisms across 5 levels: 1️⃣ bCPAP device 2️⃣ Local partnerships & infrastructure 3️⃣ Clinical & technical teams 4️⃣ Caregivers & community 5️⃣ Institutional practices

110

Luke Davis, MD @ldavismd.bsky.social · 13/12/2024

3/ Our review sought to understand how implementation context influences bCPAP outcomes. Past reviews suggested context-dependence but lacked a theory-driven framework.

110

Luke Davis, MD @ldavismd.bsky.social · 13/12/2024

2/ Previous studies on bCPAP for children with respiratory distress showed mixed results. While it reduced mortality in some cases, a major trial highlighted increased mortality for kids with severe pneumonia. Why the disparity? Context matters.

100

Luke Davis, MD @ldavismd.bsky.social · 13/12/2024

New research out from Dr. Nadir Ijaz of the Yale School of Medicine on bCPAP implementation 1/ bCPAP therapy has shown promise in saving children’s lives in LMICs, but its success often depends on context. 🧵

130